# Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke

> **NCT00153946** · PHASE4 · COMPLETED · sponsor: **Combination Therapy for Acute Ischemic Stroke Study Group** · enrollment: 814 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Edaravone

## Key facts

- **NCT ID:** NCT00153946
- **Lead sponsor:** Combination Therapy for Acute Ischemic Stroke Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2008-03
- **Final completion:** 2008-05
- **Target enrollment:** 814 (ACTUAL)
- **Last updated:** 2008-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153946, "Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00153946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*